Phio Pharmaceuticals Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
26 Feb 24 | BuyUS$2,275 | Robert Bitterman | Individual | 2,500 | US$0.91 | |
01 Jul 23 | BuyUS$5,720 | Robert Bitterman | Individual | 2,000 | US$2.88 | |
14 Jun 23 | BuyUS$6,200 | Robert Ferrara | Individual | 2,000 | US$3.10 |
Insider Trading Volume
Insider Buying: PHIO insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Private Companies | 5,713 | 0.234% |
Individual Insiders | 29,884 | 1.22% |
Institutions | 186,373 | 7.63% |
Hedge Funds | 330,118 | 13.5% |
General Public | 1,891,359 | 77.4% |
Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 112.4%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
172,693 | US$125.2k | 10.7% | 0.96% | |||
157,425 | US$114.1k | 0% | 0.03% | |||
31,843 | US$23.1k | 0% | no data | |||
24,380 | US$17.7k | 0% | no data | |||
23,486 | US$17.0k | 0% | no data | |||
21,056 | US$15.3k | 6.85% | no data | |||
20,000 | US$14.5k | 0% | no data | |||
19,044 | US$13.8k | 0% | no data | |||
16,916 | US$12.3k | 58.6% | no data | |||
15,229 | US$11.0k | 0% | no data | |||
14,233 | US$10.3k | 0% | no data | |||
13,490 | US$9.8k | 85% | no data | |||
5,754 | US$4.2k | 97.1% | no data | |||
5,713 | US$4.1k | 185% | no data | |||
4,500 | US$3.3k | 0% | no data | |||
2,740 | US$2.0k | 0% | no data | |||
1,700 | US$1.2k | 0% | no data | |||
1,700 | US$1.2k | 0% | no data | |||
125 | US$90.7 | 0% | no data | |||
41 | US$29.8 | 0% | no data | |||
19 | US$13.8 | 18.8% | no data | |||
1 | US$0.7 | 0% | no data |